Aerosol chemotherapy for pancreatic cancer spread in the abdomen
Treatments studied
Part of Cancer clinical trials.
This trial tests a treatment called PIPAC, where chemotherapy is sprayed as a mist into the abdomen during a minimally invasive surgery. It is for people whose pancreatic cancer has spread to the lining of the belly, and aims to see if this approach is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have pancreatic cancer that has spread to the lining of the abdomen, confirmed by scans or biopsy.
- You should be 18 years or older and able to give informed consent.
- You should be well enough to walk and take care of yourself most of the time (ECOG score 0–2).
- Your blood counts (white cells, platelets, hemoglobin) and liver and kidney function must be within certain limits.
- You should not have a bowel blockage or very large amounts of fluid in the belly (ascites >5 liters).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This trial tests a combination of chemotherapy drugs (NALIRIFOX given through a vein plus paclitaxel given directly into the abdomen) for people with pancreatic cancer that has spread to the lining of the belly but not to other organs. The goal is to see if this approach is safe and effective.
This Phase 1 trial tests PIPAC, a way to deliver anti-cancer medicine directly into the abdomen using a minimally invasive procedure. It is for people with peritoneal spread from certain cancers to see whether this approach is safe and potentially helpful.
This trial tests a new way to deliver chemotherapy directly into the abdomen using a spray (called PIPAC) in people with stomach cancer that has spread to the lining of the belly. The aim is to see if it can help control the cancer with fewer side effects.
This Phase 2 study tests whether spraying chemotherapy into the abdomen (through a small procedure) after colon cancer surgery can lower the chance the cancer comes back. It is meant for people with high-risk tumor features but who have had surgery and have no proven relapse yet.
Hear when a new Adenocarcinoma Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.